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ABSTRACT 
 




The ascomycetes S. cerevisiae and C. albicans metabolize the pentose sugar 
xylose differently. S. cerevisiae cannot grow on xylose as the sole carbon source while C. 
albicans can. In the xylose-metabolic pathway, xylose is reduced to xylitol by a xylose 
reductase (GRE3), then oxidized to xylulose by a xylose dehydrogenase (ScSOR1, 
CaXYL2). These two enzymes are essential for the xylose metabolic pathway. Although 
S. cerevisiae does not grow in xylose medium, it has been shown that the enzymes have 
enzymatic potential when used to complement various C. albicans knockouts. C. albicans 
was used as a model to study the function of various pairings of the reductase and 
dehydrogenase from the two ascomycetes. Transcription profiling confirmed the presence 
of GRE3 and XYL2 in growing strains and the absence in non-growing strains. It was 
found that the CaGRE3 possessed an N-terminal extension that improved the functioning 
of heterologous GRE3/SOR1 combinations. Metabolite analysis showed increased import 
of xylose when subject to xylose adaption compared to unadapted strains. C. albicans is 
able to use glucogenic amino acids as a source of carbon, with or without the presence of 
xylose enzymes. Overall, this work establishes the enzymatic interactions between the 
xylose reductase and xylose dehydrogenase in S. cerevisiae and C. albicans, as well as 
their effects on the cell. 
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Introduction 
 Candida albicans is a commensal human fungus that is a common component of 
mucosal surfaces and of the gastrointestinal tract (Beck-Sagué & Jarvis, 1993) . It is an 
opportunistic pathogen, and can be a significant threat for immunocompromised people 
(Beck-Sagué & Jarvis, 1993; Klein et al., 1984). The treatment of C. albicans infections 
is estimated to cost at least $1 billion annually in North America (Miller, Hajjeh, & 
Edwards, 2001), and it is identified to be the fourth most common nosocomial infection 
in US hospitals. C. albicans has the ability to grow in unicellular yeast, pseudohyphal and 
hyphal forms, which makes the pathogen’s life cycle and biology interesting (Beck-Sagué 
& Jarvis, 1993; Sudbery, Gow, & Berman, 2004).  The ability to grow in different 
cellular forms is considered to be a component of the organism’s repertoire that makes it 
a successful commensal and pathogen, because different forms can be useful in 
exploiting different niches within the human body. 
Differential carbon source utilization can also aid this opportunistic pathogen in 
its ability to exploit different niches. It has been shown that C. albicans uses different 
carbon metabolic pathways at different stages of an infection, an approach that might be 
crucial for the establishment of the invasive disease (Barelle et al., 2006; Beck-Sagué & 
Jarvis, 1993; Klein et al., 1984). In the early stages of infection, C. albicans upregulates 
the glyoxylate and gluconeogenic pathways, after phagocytosis by neutrophils and 
macrophages, where glucose is in relatively short supply (Lorenz, Bender, & Fink, 2004; 
Miller et al., 2001). However, in the later stages of infection, when C. albicans colonizes 
internal organs such as the kidney, which is glucose-rich, the glycolytic pathway 
predominates (Barelle et al., 2006). Mutations in each of these central metabolic 
pathways attenuate the virulence of C. albicans, suggesting that the three pathways are 
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necessary for the establishment of a systemic infection. C. albicans can also undergo 
phenotypic transitions between forms designated as white and opaque (Huang, 2012). It 
has been shown that white cells express a fermentative profile of metabolism related 
genes, while opaque cells adopt an oxidative one (Lan et al., 2002). It has been suggested 
that that the niche-specific regulation of carbon metabolism increases the biological 
fitness of C. albicans within its host (Barelle et al., 2006). 
In the model yeast S. cerevisiae, growth in glucose as the sole carbon source 
represses the transcription of numerous genes in alternative carbon pathways, a process 
termed glucose repression (Carlson, 1999). Yeast grown with an alternative carbon 
source (i.e. galactose or glycerol) undergoes catabolite de-repression. During catabolite 
de-repression, yeast metabolism shifts from fermentation to respiration and carbon is 
directed to the TCA cycle, hence increasing electron transport and respiration (Lin et al., 
2002). During catabolite de-repression, there is an increased gene expression in yeast 
amino acid permeases, amino acid uptake and oxygen consumption (Peter, Düring, & 
Ahmed, 2006). It has been shown that C. albicans can utilize amino acids as a source of 
energy, without the presence of any sugar (Lorenz, 2013). When S. cerevisiae undergoes 
carbon catabolite de-repression, intracellular transport of L-arginine and L-leucine 
increases by 10-25 fold (Peter et al., 2006). For example, L-leucine is a common 
intermediate of major catabolic pathways such as acetyl-CoA, pyruvate or 2-oxoglutarate 
(Hothersall & Ahmed, 2013).  
The baker’s yeast S. cerevisiae lineage is consistent with the universal genetic 
code in that it uses the codon CTG to encode leucine, whereas the fungal pathogen C. 
albicans encodes CTG for serine. These ascomycetes have diverse ecological niches. S. 
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cerevisiae is a nomadic yeast with no niche, whereas C. albicans is a human commensal 
pathogen that resides on mucosal surfaces in the gastrointestinal system (Bezerra et al., 
2013; Goddard & Greig, 2015). These different niches can be exploited by adaptations 
permitting cells to live in different environments. For example, baker’s yeast is limited to 
metabolizing 6-carbon sugars whereas the fungal pathogen can grow on xylose and adapt 
to various stressful environments (A. J. P. Brown et al., 2014b). For example, upon 
internalization by macrophages, the fungal pathogen utilizes the amino acids of immune 
cell for conversion into either acetyl-CoA or TCA intermediates, which would eventually 
be fluxed into the gluconeogenic pathway.  
The commonly used yeast for biofuel production, Saccharomyces cerevisiae, is 
unable to utilize pentose sugars, which includes a considerable portion of lignocellulosic 
biomass (Matsushika, Inoue, Kodaki, & Sawayama, 2009). Glucose (60-70%) and xylose 
(30-40%) are the most abundant sugars in cellulosic hydrolysates and are abundant in the 
biosphere (Mosier et al., 2005), and these could be a source of renewable liquid fuels.  
Ideally, it would be best to use sugars that we don’t eat for ethanol fermentation, so 
efficient and rapid utilization of xylose would be a important component of producing 
biofuels and chemicals from renewable biomass, sustainably and economically 
(Somerville, 2007). The ability to improve xylose catabolism and conversion in a 
recombinant host such as S. cerevisiae would increase the potential of improving biofuels 
and biochemical production. Bioethanol is being produced from starchy biomass, corn 
food as raw material, wheat starch and cane sugars, which could consequently create a 
competition between food and fuel. While S. cerevisiae cannot metabolize xylose, it can 
utilize xylulose as the sole carbon source, suggesting that S. cerevisiae lacks the 
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enzymatic capacity to convert xylose to xylulose (Deng & Ho, 1990). Although S. 
cerevisiae cannot grow on or ferment xylose, it was found that S. cerevisiae, S. pombe 
and other yeasts were able to ferment xylulose. Other yeast strains such as P. tannophilus 
and S. stipitis, have been reported to ferment xylose into ethanol but the rate and yield of 
these xylose-utilizing strains were considerably less compared to their glucose 
fermentation (Slininger, Bothast, Van Cauwenberge, & Kurtzman, 1982). Microbial 
strain development through the requirement of economic fermentation of pentose sugars 
to ethanol has been a very active field. Genetic engineering and adaptation may be 
potential methods to develop sufficient xylose fermentation in S. cerevisiae.  
The first determining step in xylose catabolism is the transport of xylose into the 
cell (Young, Poucher, Comer, Bailey, & Alper, 2011). In S. cerevisiae, xylose is 
transported by members of the HXT family of hexose transporters which have a much 
higher affinity for glucose when compared to xylose (Saloheimo et al., 2007). Once 
xylose is transported into the cell, one of two main assimilation pathways can be utilized 
(Young, Lee, & Alper, 2010). In yeasts, filamentous fungi and other eukaryotes, this 
proceeds via a two-step reduction and oxidation through the heterologous expression of a 
xylose reductase (XR) and a xylitol dehydrogenase (XDH)(Figure 1) (Hahn-Hägerdal, 
Karhumaa, Jeppsson, & Gorwa-Grauslund, 2007). However, studies have shown that this 
pathway is limited from a cofactor imbalance with the reductase utilizing NADPH while 
the dehydrogenase utilizes NAD+, which can lead to a decrease in ethanol yield (Young 
et al., 2010). This disparity could be due to competition for NAD+ by other endogenous 
metabolic enzymes or to inefficient xylose pathway enzymes. In bacteria, an alternative 
pathway for xylose catabolism exists (Figure 1). This consist of an isomerase-based 
  5 
pathway which does not require any cofactors (Brat, Boles, & Wiedemann, 2009). 
Studies have shown successful expression of xylose isomerase genes from Piromyces sp. 
and Orpinomyces sp. in S. cerevisiae which improved the knowledge of efficient xylose 
fermentation (Madhavan et al., 2009).  
The related ascomycete, Candida albicans, is able to grow on xylose but is unable 
to ferment xylose to ethanol. S. cerevisiae and C. albicans contain highly similar genes 
that encode the XR and XDH genes. It has been reported that the xylose utilization of a 
C. albicans strain deleted for its XR/XDH genes can be complemented by the S. 
cerevisiae XR/XDH genes (Harcus et al., 2013). This rescued strain, called CA271, is 
able to utilize xylose but with very weak ability compared to the wild type or either 
singly complemented strains. It has been suggested that the S. cerevisiae XR/XDH 
proteins may not be perfectly connected to the other parts of the metabolic pathways of 
C. albicans, as saturated growth of CA271 on xylose takes three weeks (Figure 2A, 2B). 
It appears the proper coupling of all the steps in the xylose metabolic pathway is as 
important as the enzyme activities. 
 A sequence alignment of the xylose reductases of the fungal kingdom showed that 
the C. albicans GRE3 ,which functions to metabolize xylose, had an N-terminal sequence 
motif extension compared to the reductases of other yeasts (Figure 3). We wanted to 
investigate whether this N-terminal extension posed an advantage to the GRE3 enzymatic 
function, since it has been shown that sugar transport preference and kinetics can be 
rewired through the insertion of a specific sequence motif (Young, Tong, Bui, Spofford, 
& Alper, 2014).  
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 Metabolomics is the study of global changes in the entire metabolome in a single 
organism. Its workflow consists of metabolite sample extraction, quenching, extraction 
and the analysis of metabolites using analytical or statistical tools (Ryan & Robards, 
2006). Metabolomics has been suggested as a more rational and systematic approach for 
strain improvements by identification of target metabolites (van der Werf, Jellema, & 
Hankemeier, 2005). In the first step of utilizing exogenous sugars, the molecular 
transport of xylose into the cell can serve as a significant flux bottleneck (Young et al., 
2014). Here, we use metabolite analysis to determine the differences in xylose uptake, 
intracellular concentrations and metabolism that result from the different combinations of 
xylose reductase and dehydrogenase. 
 We report the metabolic engineering of the xylose reductase gene in CA271 for 
improved cell growth. Metabolic engineering is a candidate approach for tailoring 
proteins that require refined functions (such as higher stability, substrate specificity, 
product selectivity of protein). We also investigated metabolic adaption as well as 
metabolic engineering using selection for increased cell growth on xylose as a sole 
carbon source to investigate what makes the XR/XDH module in C. albicans work 
compared to that of S. cerevisiae. We also report the difference between C. albicans and 
S. cerevisiae, of which the fungal pathogen can shift its metabolism in response to new 
environments, such as being able to grow in a glucogenic amino acid environment. 
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Materials and Methods 
 
Strains and Culture Conditions 
The C. albicans strains used in this study are listed in Table 3. Strain SC5314 is a 
clinical isolate, mutants gre3, xyl2 and gre3/xyl2 were constructed from parent strain 
SN148 (Harcus et al., 2013). CDH139, CA256 and CA271 were constructed by 
complementing the mutant strains with either ScGRE3 and/or ScSOR1 using the 
CIpACT1-CYC vector (Harcus et al., 2013). CA271 Adapted strains were created by 
growing CA271 on a xylose medium prior to liquid growth. AL001 was created by 
integrating pAL001 digested with MluI and the N-terminus of CaGRE3 to create the 
CaScGRE3 gene through homologous recombination. AL002 and AL003 were created by 
complementing gre3 and CA270 with pAL003. Wild type and gre3/xyl2 used as 
baselines when assaying growth curves. 
Candida albicans and Saccharomyces cerevisiae yeast strains were grown at 30
o
C 
in yeast peptone dextrose (YPD) or synthetic complete (SC)(0.67% Difco yeast nitrogen 
base with amino acids) with filter sterilized D-xylose (SX)(2%), all supplemented with 
adenine and uridine. E. coli strain DH5α grown at 37oC in Lysogeny-Broth (LB) broth 
with 225 RPM orbital shaking and was used for all cloning and plasmid propagation. 
Yeast and bacterial strains were stored at -80
o
C in 20% glycerol. 
 
Growth Curves 
 Overnight cell cultures were grown in YPD medium containing dextrose (2%). 
Cells were washed three times with two volumes of the starting-culture-volume of sterile 
water before diluting to an OD660 nm of 0.2 in 5-10 ml of synthetic complete medium 
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containing xylose (2%). Cells were grown aerobically at 30
o
C with 225 RPM orbital 
shaking, and the OD660 nm was taken at intervals for up to two weeks.  
When doing growth curves in 50mL falcon tubes (for strains requiring more than 
a five days to grow), a spectrophotometer was used to measure optical density. Cells were 
diluted to an OD660nm of 0.1 in 10mL of media. Cells were grown aerobically at 30
o
C 
with 220 RPM orbital shaking, and the OD660nm was taken at daily intervals. When 
doing growth curves in 96-well plates (for strains that require five days or less to grow), 
the TECAN Sunrise machines were used. In these experiments, cells were diluted to an 
OD660nm of 0.1 in 200uL of media. Cells were grown aerobically at 30
o
C with 200 
RPM orbital shaking at every ten-minute-interval, and the OD660nm was taken at 10-
minute intervals for five days. 
 
Microarray Analysis 
 The strains SC5314, gre3/xyl2 and CA271 of C. albicans were used for 
transcription profiling in xylose medium. A 10mL starting culture in 2% YPD was grown 
overnight. The cells were then washed three times with 20mL sterile water. The cell 
pellet was suspended in 20mL of water and was used to inoculate 50mL culture in 2% 
xylose at a starting OD600 of 0.1. These cultures were incubated until an increase in 
OD600 was observed to approximately 0.6 – 0.8. For the gre3/xyl2 strain, the starting 
OD600 used was 0.8, since there was no increase in the OD600 for that strain in xylose 
medium. 
 Cells were disrupted with glass beads in the FastPrep®-24 instrument (MP 
Biomedicals). RNA was extracted using the RNeasy® Kit (QIAGENTM), and 20 ug of 
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total RNA was used for the cDNA synthesis with either cyanine-3 or cyanine-5 dyes. 
Probe synthesis, microarray hybridizations, washings and analyses were as described 
(Nantel, Rigby, & Hogues, 2006). C. albicans microarrays (double-spotted 6,394 
intragenic 70-mer oligonucleotides) were obtained from the Biotechnology Research 
Institute Microarray Facility Center. To obtain the gene list, the median of ratios (which 
shows the intensity of color, 635nm/532nm or vice-versa, depending which strain was 
going to be compared to) was taken for each gene. Since duplicates were performed, the 
average of the median of ratios was calculated for each gene. It is these ratios that 
determine the difference in expression between two strains. 
 
Protein Engineering of GRE3 
Plasmids and oligonucleotides in this study are listed in Table 1 and 2. Two 
plasmids were used for this construction: CIpACT1-CYC which contains the C. albicans 
ACT1 promoter, CYC1 terminator and RPS1 gene, to allow the cloned gene of interest to 
be integrated at the RPS1 locus and expressed under the control of the ACT1 promoter, 
and pRS314 which contains the CEN/ARS sequence and ScGRE3 that was previously 
cloned between the MluI/NheI sites of CIpACT1-CYC to produce pl396 (Harcus et al., 
2013). That plasmid was digested with KpnI/SpeI and the fragment that contained 
ScGRE3 was ligated into the sites of KpnI/SpeI of pRS314 to produce pAL001 (Figure 
6A, lane 6). The coding region for the N-terminal part of CaGRE3 was amplified by PCR 
from C. albicans (SC5314) genomic DNA with primers OAL001/002 with homology 
with the ACT1 promoter before the CaGRE3 N-terminal and homology with the N-
terminal region of ScGRE3 after the CaGRE3 N-terminus. The CaGRE3 PCR fragment 
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and pAL001 (linearized with a MluI digest) were transformed into S. cerevisiae strain 
W303-1A to induce homologous recombination between ACT1p and the N-terminal of 
ScGRE3 to produce pAL002 (Figure 6A, lane 9). The plasmid pAL002 was digested with 
KpnI/SpeI once again and the fragment containing the fusion gene was cloned at the 
KpnI/SpeI sites of CIp-ACT1-CYC to produce pAL003 (Figure 6A, lane 11). The new 
plasmid was linearized with a StuI digest and transformed into C. albicans gre3 and 
CA270 carrying the CaScGRE3 genes to create AL001 and AL002, respectively. The 
genomic DNA of these strains was isolated to perform PCR to confirm integrity of the 
homologous recombination with primers OAL003/004, which are specific to CaGRE3 
and ScGRE3, and products were sent for sequencing at Genome Quebec (Submission 




Standards for metabolite analysis 
Standards of xylose, xylitol and xylulose at >99% purity were purchased from 
Sigma-Aldrich (St. Louis, MO). Water and Acetonitrile of LC-MS grade were purchased 
from Fisher Scientific (Ottawa, Canada). Ammonium acetate of HPLC grade was 
obtained from Merck (Darmstadt, Germany). 
 
Sample preparation 
A standard sample containing 500 ng/ml of carbohydrates (xylose, xylulose and 
xylitol) was freshly prepared in 95:5 of acetonitrile/water (v/v). Calibration solutions 
were obtained by successive dilutions of the standard sample to final concentrations of 
250, 125, 62.5, 31.3 and 15.5 ng/ml. Overnight cultures were grown in YPD, washed and 
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grown in SX media until saturation. The cultures were washed with water to exclude any 
extracellular metabolites. Cells were suspended in cold 1:1 acetonitrile/water, vortexed 
for cell lysis, followed by centrifugation. The supernatant was extracted and suspended in 
cold 1:1 acetonitrile/water. The resulting extract was diluted 1:2 with 95:5 of 
acetonitrile/water 2 mM ammonium acetate and centrifuged for 5 min at 13,000 RPM 
prior to LC-MS injection.  One set of spiked samples containing 250 ng/ml of each 
carbohydrate was also prepared to estimate degree of ionization suppression across the 
different extracts.  
 
HILIC separation of carbohydrates and detection by mass spectrometry 
A HP 1100 HPLC system (Agilent Technologies, Mississauga, Canada) was used 
for the analysis of carbohydrates. Separations were performed using an Ascentis Express 
HILIC 2.7 μm (100 cm × 2.1 mm) column (Sigma-Aldrich, St. Louis, MO) at a flow rate 
of 300 μL/min. Injections of 10 μL of samples were made onto the column. 
Carbohydrates were eluted using a mobile phase gradient in solvent A [95:5 of 
acetonitrile/water 2 mM ammonium acetate] and solvent B [60:40 of acetonitrile/water 2 
mM ammonium acetate] as follows: 0–2 min, 100% A, 2-14 min linear gradient to 35% 
A, 14-18 min, isocratic hold at 35% A, 18-18.10 min, linear gradient to 100% A, and 
18.10-30 min, column re-equilibration to 100% A. 
A Thermo Fisher Scientific Velos LTQ Orbitrap high-resolution mass 
spectrometer (Thermo Fisher Scientific, Bremen, Germany) was used for the acquisition 
of the MS data in negative electrospray ionization (ESI) mode. The mass spectra were 
recorded over a scan range of 100−1000 Da at a resolution of R = 100,000. Instrumental 
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settings were as follows: sheath and auxiliary gas flow rates 30 and 10, respectively; 
spray voltage 3.0 kV, capillary temperature 350 °C. LC-MS data analyses were 
performed using Thermo Scientific Xcalibur 2.1 software supplied by the manufacturer. 
The amount of xylose, xylulose and xylitol was determined using MS1 extracted ion 
chromatograms of m/z 149.0455 and 151.0612 using external standard calibration 
method and 10 ppm extraction window. 
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Results 
In fungi, the metabolism of xylose involves the conversion to xylulose in a two-
step process. First, xylose is reduced to xylulose by a xylose reductase (XR), second, 
xylitol is oxidized to xylulose by a xylose dehydrogenase (XDH) (Figure 1). It has been 
shown by Harcus et al. that C. albicans mutant strains gre3, xyl2, gre3/xyl2 did not grow 
on media supplemented only with xylose as a carbon source. When complemented with 
ScGRE3, ScSOR1 and ScGRE3/ScSOR1 respectively, the ability to grow in xylose 
medium is restored. However, the growth phenotype is not rescued to that of the wild 
type C. albicans. It was observed that it takes the complemented gre3 (CA256) three to 
four days to grow, the complemented xyl2 (CDH139) seven to eight days to grow and the 
double complemented gre3/xyl2 (CA271) about twenty-one to twenty-four days to grow, 
while the wild type strain reaches saturation after only 2 days (Figure 2A, 2B). All of the 
complemented strains as well as the gre3 mutant were able to grow on xylitol after one to 
two days (Figure 2D), suggesting that the XDH from both S. cerevisiae and C. albicans 
can metabolize xylitol but when coupled with the XR to metabolize xylose, a variable lag 
period appears in the complemented strains (Figure 2B). We were interested in the 
differences in the xylose enzymes in C. albicans and S. cerevisiae that cause these 
distinctions. 
 
Transcription profiling of cellular response to xylose 
 Previous work as established that in response to the presence of xylose, S. 
cerevisiae does not induce the genes for XR and XDH, but does induce the sugar 
transporter encoding genes HXT4, HXT6 and HXT7 (Harcus et al., 2013), even though the 
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strain shows no growth under these conditions.  We have examined the response to 
xylose of C. albicans wild type, gre3/xyl2 and CA271 through incubation of the cells 
with xylose as the sole carbon source. In Figure 4A, wild type is compared to gre3/xyl2 in 
xylose growth conditions. Thirty eight genes have at least a 2-fold transcription increase 
in xylose when compared to the null mutant, and 10 of these genes have more than a 10-
fold increase. The differentially expressed genes include GRE3 and XYL2, due to the fact 
that the wild type has the XR and XDH while the null mutant does not, confirming the 
detection capacity of the microarrays. Several genes encoding glycolytic enzymes and 
sugar transporters (HGT19, HGT20) are also up-regulated, these are different sugar 
transporters compared to the profiling done by Harcus et al.. Other notable genes that 
were highly up-regulated are LDG3 (243 fold) and INO1 (18 fold) genes. This shows the 
baseline between cells that grow in xylose, versus cells that cannot. When comparing 
CA271 to gre3/xyl2, it was observed that 75 genes had at least a 4-fold transcription 
increase in CA271 when incubated in xylose, of which 8 genes had more than a 10-fold 
induction (Figure 4B). One of the induced genes included GRE3 (103 fold), but not 
XYL2. When the DNA sequence of CaGRE3 and ScGRE3 were aligned using BLAST, 
the sequence identity showed a high sequence identity (E-value) of 5.9 x 10
-54
, compared 
to the DNA sequence identity between CaXYL2 and ScSOR1, which was considerably 
lower with an E value of 2.7 x 10
-14
. This supports the idea that the C. albicans 
microarray chip can detect ScGRE3 but not ScSOR1. Notable genes that were highly up-
regulated were LDG3 (23 fold) and INO1 (16 fold). When comparing wild type to 
CA271, it was observed that only 9 genes had at least 4-fold transcription induction in the 
wild type when incubated in xylose, of which 4 genes had more than a 10-fold induction 
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(Figure 4C). One of the induced genes includes XYL2 (95 fold), but not GRE3 (no change 
in expression). This could arise because both CaGRE3 and ScGRE3 could be detected 
from the C. albicans microarray chip but not ScSOR1. As a result, since only CaXYL2 is 
detected, it appears highly induced in the wild type. One of the notable genes INO1 (16 
fold) was induced once again. The other notable genes LDG3, that was induced when 
comparing either the wild type or CA271 to gre3/xyl2, had no change in expression, 
suggesting that LDG3 is induced when cells are in good conditions of growth. 
 
Identification of Adapted CA271 Mutants 
 It has been proposed that C. albicans has certain traits that allow it to adapt and 
grow in its new niches compared to a non-pathogenic yeast like S. cerevisiae. It has been 
proposed that metabolic adaptation impacts C. albicans pathogenicity and 
immunogenicity at multiple levels (A. J. P. Brown, Brown, Netea, & Gow, 2014a). I 
asked whether CA271 mutants could be generated that would show improved growth 
when streaked on 2% xylose plates. The goal was to obtain CA271 colonies that had 
undergone spontaneous genetic mutations to improve growth that could possibly map to 
either the heterologous XR or XDH genes. When gre3/xyl2 and CA271 were grown on 
xylose plates for six days, colonies were observed for both strains (Figure 5A). This was 
unexpected because the gre3/xyl2 mutations were non-revertable deletions, but it was 
possible that the gre3/xyl2 strain was exploiting alternative carbon sources in either the 
YNB or the agarose. We wanted to understand this phenomenon so colonies were picked 
and inoculated in 2% xylose media; 36 gre3/xyl2 revertant colonies and 60 CA271 
revertant colonies from the xylose plate were picked and assessed. It was observed that 
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none of the gre3/xyl2 revertants grew in liquid xylose media while all of the CA271 
colonies grew to saturation (Figure 5B), suggesting that although the two strains 
generated similar numbers of colonies, these colonies were arising from distinct events in 
the two strain backgrounds. The CA271 colonies were termed “adapted” because they 
had an improved ability to grow in liquid medium with xylose as the sole sugar source. 
To further investigate the properties of these CA271 derived colonies, an adapted-
evolution growth assay was performed to determine whether the xylose growing CA271 
strains had undergone either genetic (stable) or physiological (transient) changes. The 
double complemented strain was subjected to three different environments before being 
assessed in xylose media: first, CA271 was streaked on a YPD plate; second, CA271 was 
streaked on a SX plate; third, CA271 was streaked on a SX plate, then replica plates on a 
YPD plate; colonies from these three scenarios were assessed in xylose media 
(Supplementary 5). Our hypothesis was that the first and third scenario would arrive at 
the same outcome, as their final environment comes from glucose. We predicted the 
second environment to show the most growth on xylose as it had the chance to adapt. It 
was observed that the second and third scenarios showed improved growth compared to 
the first scenario (Supplementary 6). It was observed that in the third scenario, when the 
adapted CA271 strains were grown on YPD, they did not de-adapt, suggesting that this 
adaption was not physiological, and growing CA271 on a SX plate gave C. albicans the 
inherited ability to grow in a new environment To investigate whether there were any 
genetic changes within the XR/XDH of the adapted CA271 strains, these genes were 
sequenced; there were no genetic changes suggesting that xylose adaptation may be 
altering the genome outside of the XR/XDH genes. 
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Assessing the Role of the N-terminus of CaGRE3 
The XR/XDH module of C. albicans permits the fungal pathogen to efficiently 
metabolize xylose as a sole carbon source. However, the XR/XDH module of S. 
cerevisiae, when introduced into C. albicans, functions poorly compared to the 
endogenous C. albicans module and the single complemented strains. This could be due 
to protein stability, localization and/or expression levels. Comparative genomic studies 
have shown that the XR and XDH genes from S. cerevisiae are well conserved when 
compared to the orthologs in xylose metabolizing fungi such as C. albicans. Since the 
genes are structurally well conserved, we asked the question why the combined XR/XDH 
enzymes of S. cerevisiae are functioning so poorly within the heterologous host. 
Alignment of xylose reductase showed that the N-terminus of C. albicans Gre3p has a 
unique 55 amino acid extension that is missing in S. cerevisiae Gre3p. Compared to other 
fungal orthologs of GRE3, the C. albicans Gre3p has the largest N-terminal extension 
(Figure 3). To investigate this N-terminal extension, we fused this N-terminal region of 
the C. albicans GRE3 to the N-terminus of the S. cerevisiae GRE3, and expressed this 
hybrid enzyme in C. albicans. The GRE3 fusion protein was constructed by using 
restriction enzyme sites and the homologous recombination machinery in yeast. The 
engineered CaScGRE3 gene contained no CTG codons. When complementing CA270 
with CaScGRE3 at the RPS1 locus, there was a 50% probability that the CaScGRE3 gene 
integration would incorporate at the correct diploid locus; alternatively the integration 
would replace the existing ScSOR1 integration at the other RPS1 locus (Figure 6C). PCR 
was performed on genomic DNA of AL003 transformants to confirm the presence of 
CaScGRE3 and ScSOR1. Successful transformants had both the xylose genes integrated 
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at the RPS1 locus while unsuccessful transformants showed the presence of CaScGRE3 
but not ScSOR1 (Figure 6D). When C. albicans strains gre3 and CA270 were 
complemented with the chimeric CaScGRE3, it was observed that their growth was 
significantly improved in xylose medium compared to the strains without the chimeric 
Gre3p, CA256 and CA271, respectively (Figure 6E). The growth of AL002 relative to 
CA256 was improved by 4 fold and the growth of AL003 relative to CA271 was 
improved by 23 fold. To examine how the engineered XR could be significantly 
improving growth in C. albicans, a 3D model of Candida tenuis GRE3p was closely 
looked at using the program JMol. It was observed that the active site of GRE3p resides 
in the center of the TIM barrel, distant from the N-terminus. Since the modified N-
terminus is on the opposite side from the active site, it is unlikely that the modification is 
increasing the catalytic function of the enzyme; it could be that the chimeric GRE3 is 
interacting better with the XDH, improving the function of the XR/XDH module. 
 
Metabolite analysis of Wild Type, CA271 and Adapted Strains 
 To understand the way different C. albicans strains metabolize xylose, metabolite 
analysis was performed to observe a physiological-snapshot of the cell during xylose 
metabolism during the logarithmic phase of cell growth. The metabolite analysis of C. 
albicans strains wild type, CA271 and four CA271 adapted strains (D1, D2, D3, D4) was 
examined. When creating the standard curves for xylose, it was observed that D-xylose 
had two different mass peaks observed at two different retention times. To confirm that 
there was no contamination, NMR was performed on the two peaks (data not shown). It 
was observed that D-xylose had two isomers at a 50% proportion, α- and β-D-xylose. To 
  19 
ensure reproducibility, five replicates of the WT strain were analyzed for xylose, xylitol 
and xylulose, there was less than 5% variability between the replicates (data not shown). 
Xylose samples showed 15% variability while xylitol and xylulose showed 5% 
variability. It was observed that WT had relatively the lowest concentrations of 
intracellular xylose compared to CA271 and the adapted strains (Figure 7A). This 
supports the idea that CaGRE3 can metabolize xylose into xylitol relatively better than 
ScGRE3. It was found that intracellular concentration of xylitol was relatively higher in 
WT compared to CA271 and adapted strains, which correlates with the results with the 
low amounts of xylose in the wild type (Figure 7B). Intracellular xylulose was found to 
be relatively higher in WT compared to CA271 and adapted strains, which correlates with 
the results with the higher amounts of xylitol in the wild type (Figure 7B). It was also 
observed that the adapted strains had slightly higher amounts of intracellular xylose, 
xylitol and xylulose. This could support the idea that the adapted strains are able to 
import more xylose than the original strain. 
 
Amino Acid Metabolism 
 Intriguingly, when performing xylose growth assessments for the C. albicans 
mutants defective in the xylose metabolic pathway genes, growth was observed for the 
mutants on the sugar free negative control (synthetic complete, no sugar)(Figure 8A). 
This was surprising and suggested that C. albicans can efficiently use some alternative 
carbon source in the medium; this could be amino acids. It had been shown that when C. 
albicans cells were phagocytized by macrophages, they were able to shift their 
metabolism from sugars to amino acids, and this allows the fungal pathogen to survive in 
  20 
its sugar-limiting environment (Lorenz et al., 2004). We further investigated the method 
by which C. albicans utilizes amino acids as a carbon source. There are two types of 
amino acids as potential carbon sources: glucogenic and ketogenic. A glucogenic amino 
acid is an amino acid that can be catabolized to pyruvate, -ketoglutarate, succinyl-CoA, 
fumarate or oxaloacetate, which are all possible gluconeogenic glucose precursors. This 
is in contrast to ketogenic amino acids, which can only be catabolized to acetyl-CoA or 
acetoacetate and thus can only be transformed into fatty acids or ketone bodies. Some 
amino acids are precursors for both carbohydrates and ketone bodies. Growth of C. 
albicans was compared in an environment where glucogenic and ketogenic amino acids 
were the only carbon source. It was observed that C. albicans can grow on glucogenic but 
not on ketogenic amino acids. (Figure 8B). In humans, there are thirteen amino acids that 
are characterized as glucogenic. Wild type C. albicans, gre3/xyl2 and S. cerevisiae were 
grown on media containing a single glucogenic amino acid as a sole possible carbon 
source. Out of the thirteen amino acids, growth was observed on seven of the glucogenic 
amino acids (serine, proline, alanine, glutamate, glutamine, aspartate, asparagine). It was 
observed that key enzymes in the other six glucogenic amino acids in humans were not 
present in C. albicans (Supplementary 1).  
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Discussion 
It has been shown that S. cerevisiae has orthologs of the xylose metabolic  
enzymes of xylose using yeasts such as C. albicans, but is not able to use them to allow 
S. cerevisiae growth in the presence of xylose as the sole carbon source. However when 
we complement these enzymes into a related ascomycete such as C. albicans, they are 
able to function either individually or as a pair. However when they work as a pair, they 
do not appear to work efficiently. We investigated the S. cerevisiae xylose enzymes by 
mutagenesis to see if we could tailor and improve their enzymatic function in C. albicans 
with the ultimate goal of also improving enzymatic function in S. cerevisiae. Microarray 
and metabolite analysis allowed us to understand how the S. cerevisiae xylose genes are 
affecting the cell in response to xylose. At the same time, we also investigated how C. 
albicans was to shift metabolic states when it is an environment with limited glucose 
supply. This could help us understand why Candida cells are pathogenic as well as how 
they survive in phagocytic cells to infect host cells.  
Whole-genome transcription profiling was performed between wild type, 
gre3/xyl2 and CA271 to understand why CA271 was not growing on par with the wild 
type. When comparing the wild type and gre3/xyl2, 38 genes have at least a 2-fold 
transcription increase in xylose when compared to the null mutant, the highest expressed 
genes included those that are critical for xylose metabolism, such as GRE3 (302 fold) and 
XYL2 (248 fold), confirming the absence of these genes in gre3/xyl2. Several genes 
encoding glycolytic enzymes and sugar transporters are also up-regulated, suggesting that 
either the enzymes or metabolites work through some positive feedback system to 
increase the expression of other metabolic genes from other pathways or transporters. 
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This analysis presented the baseline between cells that grow in xylose, against cells that 
cannot. It was observed that when comparing the wild type and CA271 against gre3/xyl2, 
there was up-regulation of INO1 and LDG3. This posed an interesting question because 
INO1 is used to convert glucose-6-phosphate (G6P) into myo-inositol, which is used for 
phosphatidylinositol biosynthesis, but there was no source of glucose in the media. LDG3 
is a putative GPI-anchored cell wall protein, suggesting that this superfamily of proteins 
could be associated with xylose. Microarray analysis showed the possibility of INO1 and 
LDG3 either being associated with xylose metabolism, or with cells in growing 
conditions. 
It was found that the XR and XDH of S. cerevisiae have the enzymatic capacity to 
metabolize xylose however, S. cerevisiae couldn’t grow on xylose as the sole carbon 
source. The proper coupling of ScGRE3/SOR1 in C. albicans has relatively weak ability 
to allow growth on xylose compared to the native CaGRE3/XYL2. We studied the 
XR/XDH module of S. cerevisiae in C. albicans in two ways. The first way to improve 
growth on xylose was to identify spontaneous mutants through metabolic adaptation. It 
was observed when gre3/xyl2 and CA271 were streaked on xylose plates, growth was 
observed after a lag period of six days, although we expected gre3/xyl2 not to grow. One 
possibility for this is that the double mutant was exploiting an alternative carbon sources 
in either the YNB or the agarose. We defined the lag period as the time it takes for the 
strain to go through metabolic adaptation. Nonetheless, when the colonies on xylose 
plates were picked off and assessed in xylose media, the gre3/xyl2 derivatives did not 
grow while the CA271 variants were able to grow to saturation. To confirm whether it 
was a physiological or genetic change, the CA271 derivatives were re-streaked on YPD 
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after being subjected to selection on xylose. Colonies for CA271 were once again picked 
off and assessed in xylose media. It was found that these colonies inherited their ability of 
xylose metabolic adaptation after being grown on glucose. It was observed that the 
growth of CA271 derivatives from metabolic adaptation were improved by 3-fold, 
compared to the original unadapted CA271. To understand whether this is caused by a 
mutation, the XR and XDH genes were sequenced. Sequencing of the xylose genes in the 
CA271 derivatives showed no genetic changes, suggesting xylose metabolic adaptation 
may be caused by alterations elsewhere in the genome. 
The second way to improve the growth on xylose was to investigate the function 
of the N-terminus of C. albicans, which has a 55 amino acid extension that is unique in 
its fungal species. A fusion protein was constructed that consisted of the N-terminus of 
CaGRE3 with ScGRE3. This mutant GRE3 was transformed into both S. cerevisiae and 
C. albicans and assessed for growth. It was observed that when the chimeric Gre3p was 
transformed into gre3 and CA270, there was significant improvement compared to their 
predecessors CA256 and CA271. There was a 4-fold increase in growth between AL002 
and CA256, and a 23-fold increase in growth between AL003 and CA271. To ensure this 
was due to the chimeric GRE3, primers were designed for the RPS1 integration site as 
well as for the chimeric GRE3 for PCR confirmation. pAL001, pAL002 and pAL003 
were re-streaked to assess plasmid stability (data not shown). This supports the idea that 
the N-terminus of CaGRE3p contributes some advantage in the coupling between the XR 
and XDH. Based on examination of the crystal structure of C. tenuis GRE3p using JMol, 
it was observed that the N-terminus is on the opposite side of the active site, suggesting 
that it is less likely that the enzymatic function of ScGRE3 has been improved 
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(Kavanagh, Klimacek, Nidetzky, & Wilson, 2002). The addition of the CaGRE3 terminus 
protrudes away from the TIM barrel active site, suggesting that the chimeric GRE3p 
could be coupling better with ScSOR1p. This hypothesis could be tested by examining 
the interaction between the chimeric GRE3p and SOR1p in S. cerevisiae. Other 
possibilities how the N-terminus of CaGRE3 is enhancing xylose metabolism could be 
that it is increasing the stability of ScGRE3, guiding the protein to a different localization, 
or creating an allosteric enzymatic function. 
To understand xylose catabolism even further, metabolite analysis was performed 
on wild type, CA271 and the CA271 adapted strains. It was observed that wild type had 
relatively lower concentrations of xylose, and compared to CA271 and adapted strains. 
This supports the idea that CaGRE3 metabolizes xylose better in Candida, than ScGRE3. 
There were relatively higher concentrations of xylitol in the wild type, suggesting that 
xylose is being metabolized to xylitol more efficiently. The same trend was observed for 
xylulose, in that there were relatively higher concentrations in the wild type, compared to 
CA271 and the adapted strains. It was also observed that the adapted strains had slightly 
higher amounts of the three metabolites. This suggests that the adapted could be more 
efficient in importing xylose, and metabolizing xylose and xylitol. It is still unknown on 
what made the adapted strains more efficient in a xylose environment compared to the 
original CA271 strain. 
It was found that C. albicans could use amino acids as a carbon source. To 
investigate this, wild type and gre3/xyl2 were subjected to glucogenic and ketogenic 
amino acids as the sole carbon source. Growth was observed on glucogenic but not 
ketogenic amino acids. This correlates with humans because glucogenic amino acids are 
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glucose precursors, whereas ketogenic amino acids are precursors for fatty acids and 
ketone bodies. This was taken one step further by growing wild type and gre3/xyl2 in 
single glucogenic amino acids. It was found that out of the thirteen amino acids, growth 
was observed on seven of the glucogenic amino acids (serine, proline, alanine, glutamate, 
glutamine, aspartate, asparagine). It was observed that key enzymes in the other four 
glucogenic amino acids in humans were not present in C. albicans. The enzymes to 
convert glycine and arginine into gluconeogenic precursors are present in C. albicans, 
although the strains did not grow. It was speculated why gre3/xyl2 was not growing in 
xylose medium, although it had the necessary amino acids to convert into gluconeogenic 
precursors. In humans, it has been shown that amino acid metabolism is decreased by a 
high carbohydrate diet, and it is increased during prolonged starvation (Felig, Owen, 
Wahren, & Cahill, 1969). This suggests that there is some regulation mechanism between 
detecting a carbohydrate environment and a low to no carbohydrate environment. It is 
interesting that despite the gre3/xyl2 not having the enzymes for xylose metabolism, the 
transported xylose in the cell and in the extracellular environment gives a signal to inhibit 
amino acid catabolism. Similar to S. cerevisiae, C. albicans possesses an amino acid 
sensing mechanism called the SPS-sensor pathway, which senses and responds to 
extracellular amino acids, which extracellular amino acids induce the proteolytic 
processing of Candida STP1 and STP2 homologs, which activates multiple systems for 
amino acid uptake (Martínez & Ljungdahl, 2005). It was found that Candida cells lacking 
the ability to respond and take up amino acids were unable to establish virulent infections 
in mouse model (Martínez & Ljungdahl, 2004). This correlates with the idea that amino 
acid catabolism is necessary for Candida to survive in its sugar-limiting niches. It was 
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suggested that sugars have some connection with the amino acid sensors in which, are 
associated with the amino acid permeases. If we knew what that connection was, it would 
help understood why Candida gre3/xyl2 is not using the glucogenic amino acids in the 
xylose medium to survive. 
Comparative genomics studies have showed that the XR and XDH genes of S. 
cerevisiae and C. albicans are well conserved. So why is it that C. albicans can grow on 
xylose and S. cerevisiae cannot? Understanding carbon metabolism in C. albicans can 
perhaps not only understand the way Candida behaves during an infection, but help us 
understand xylose metabolism in S. cerevisiae, which could potentially lead to 
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Figure Legends 
 
Figure 1. Xylose entry to the pentose phosphate pathway. The schematic presentation 
of conserved genes encoding enzymatic activities for xylose entry into the PPP pathway 
in S. cerevisiae and C. albicans. 
 
Figure 2. Metabolizing capacities of C. albicans mutants and rescued strains. (A) 
Growth of C. albicans strains in SC with 2% xylose. Strains SC5314, gre3, xyl2, 
gre3/xyl2, CA256, CDH139 and CA271 were grown aerobically at 30
o
C and the growth 
was measured over a period of 12 days in 96-well plates. (B) The xylose reductase and 
xylitol dehydrogenase genes from S. cerevisiae complement C. albicans deletion mutants 
of the corresponding genes. The C. albicans wild type SC5314 was used as a positive 
control; S. cerevisiae wild type BY4743 and C. albicans gre3, xyl2 and gre3/xyl2 were 
used as negative controls. S. cerevisiae GRE3 (CA256), S. cerevisiae SOR1 (CDH139) 
and S. cerevisiae GRE3/SOR1 complement the C. albicans gre3, xyl2 and gre3/xyl2 
mutants, respectively. Strains were grown aerobically at 30
o
C in 2% xylose. The optical 
density was measured over a period of 30 days, n =5. (C) S. cerevisiae, gre3, xyl2 and 
gre3/xyl2 were used as negative controls (first row). The C. albicans wild type SC5314, 
CA256 (gre3::ScGRE3), CDH139 (xyl2::ScSOR1) and CA271 
(gre3/xyl2::ScGRE3/SOR1) were used as positive controls (second row). gre3 and 
CA270 were complemented with CaScGRE3 to create AL002 and AL003 (third row). 
Strains were grown aerobically at 30
o
C in 2% xylose solid plates. Scans were taken daily. 
(D) Strains were grown aerobically at 30
o
C and the growth (OD) was measured over a 
period of 5 days in 96-well plates, n =12. Growth was quantified using the TECAN plate 
  31 
reader. All of the axes (x and y) are on the same scale. Rows: SC5314 (A), BY4743 (B), 
CA256 (C), CDH139 (D), CA271 (E), AL002 (F), AL003 (G). (E) S. cerevisiae, gre3, 
xyl2 and gre3/xyl2 were used as negative controls (first row). The C. albicans wild type 
SC5314, CA256 (gre3::ScGRE3), CDH139 (xyl2::ScSOR1) and CA271 
(gre3/xyl2::ScGRE3/SOR1) were used as positive controls (second row). gre3 and 
CA270 were complemented with CaScGRE3 to create AL002 and AL003 (third row). 
Strains were grown aerobically at 30
o
C in 2% xylose solid plate. Scans were taken daily. 
 
Figure 3. Alignment of the xylose reductase GRE3 in the fungal kingdom. The 
alignment was performed using the program MAFFT. There is a ~55 amino acid N-
terminal extension that is present in C. albicans that is missing in S. cerevisiae. C. 
albicans seems to have to most “extended” N-terminus relative to the other fungal 
species. 
 
Figure 4. Transcription profile of C. albicans wild type, gre3/xyl2 and CA271 in 
xylose. Microarray experiments with C. albicans grown in xylose. (A) Upregulated genes 
of wild type when compared to gre3/xyl2. (B) Upregulated genes of CA271 when 
compared to gre3/xyl2. (C) Upregulated genes of wild type when compared to CA271. 
 
Figure 5. gre3/xyl2 and CA271 grown on xylose agarose plates for six days then 
grown in xylose media for three days. (A) The strains were streaked on plates with no 
dilution (on the left), and with 1:100 dilution (on the right). (B) The first three rows 
depict gre3/xyl2 from the xylose plate and the last five rows depict CA271. It was 
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observed that only the CA271 colonies from the xylose plate were able to grow in xylose 
media. (C) Growth of adapted CA271 mutants compared to the wild type and unadapted 
CA271. Strains were grown aerobically at 30
o
C in 2% xylose. The optical density was 
measured over a period of 30 days, n = 3. 
 
Figure 6. Creation, integration and confirmation of CaScGRE3 construct. (A) 
Plasmid pl396 was digested with KpnI/SpeI to give rise to two bands: 4319bp (CIpACT1-
CYC backbone) and 2993bp (ScGRE3)(Lane 2). CIpACT1-CYC was also digested with 
KpnI/SpeI to compare the backbone with pl396 (Lane 3). pRS314 was digested with 
KpnI/SpeI (Lane 4). pRS314 and ScGRE3 were ligated to create pAL001. pAL001 was 
digested wit KpnI/SpeI to yield the pRS314 backbone as well as ScGRE3 (Lane 6). The 
N-terminus of CaGRE3 was amplified by PCR to give a band of 455bp (Lane 7). pAL001 
and the N-terminus fragment were recombined to give rise to pAL002. pAL002 was 
digested with KpnI/SpeI to give rise to two bands (Lane 9). CaScGRE3 was re-ligated 
into CIpACT1-CYC to give rise to pAL003 (Lane 10). pAL003 digested with KpnI/SpeI 
created two bands (Lane 11). (B) Confirmation of CaScGRE3 construct. pAL003 was 
amplified with primers OAL003 and OAL004 to confirm the homologous recombination 
of the CaScGRE3 gene. PCR product was sent for Sanger sequencing at Genome Quebec, 
Submission #165761, June 18
th
, 2014. (C) Different possibilities of integration of 
CaScGRE3 at the ACT1p and RPS1 locus. To re-create the double complemented strain, 
CA270 was complemented with CaScGRE3 to give rise to AL003. Since ScSOR1 was 
already present in one of the locus, CaScGRE3 had a 50% chance of integrating in the 
correct diploid locus. (D) Confirmation of successful and unsuccessful AL003 
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transformants. PCR was performed between the ACT1p and RPS1 locus from isolated 
gDNA of various transformants. Successful AL003 transformants two bands, which 
consisted of CaScGRE3 and ScSOR1. Unsuccessful transformants showed the slight 
presence of CaScGRE3 but not ScSOR1 (see Figure 6C for placement of 
oligonucleotides). (E) The xylose reductase and xylitol dehydrogenase genes from S. 
cerevisiae complement C. albicans deletion mutants of the corresponding genes. AL002 
and AL003 were complemented with the engineered CaScGRE3. CA256 was compared 
to AL002 and CA271 to AL003. Strains were grown aerobically at 30
o
C in 2% xylose. 
The optical density was measured over a period of 30 days, n =3. 
 
Figure 7. Metabolite analysis of intracellular xylose, xylitol and xylulose during mid-
log phase of growth. (A) The relative ratio (compared to WT) of xylose was measured 
between CA271 and four adapted strains. CA271 had ≈5 times more xylose than the WT. 
The adapted strains had relatively slightly more xylose than CA271. (B) The relative ratio 
(compared to WT) of xylitol and xylulose was measured between CA271 and four 
adapted strains. CA271 had ≈5 times less of the two metabolites compared to the WT. 
The adapted strains had relatively slightly more xylitol and xylulose compared to CA271. 
 
Figure 8. Assessment of WT, gre3, xyl2, gre3/xyl2, CA256, CDH139 and CA271 on 
xylose and amino acids. (A) Mutants for gre3 and/or xyl2 were not able to grow on 
xylose. However, when these strains grow on amino acids as the sole carbon, growth was 
observed over a period of 2-3 days. Serial dilutions were created for each strain, from left 
to right. (B) Growth of WT and gre3/xyl2 was observed over a period of eight hours on 
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either glucogenic or ketogenic amino acids. Both medias were supplemented with 
adenine and uridine for Candida albicans. (C) WT and gre3/xyl2 were grown on 13 
single glucogenic amino acids from H. sapiens. Out of the 13, growth was observed on 
seven of the glucogenic amino acids. The OD for WT and gre3/xyl2 were very similar 
and compiled into one curve. Growth was measured over 7 days. 
 
Figure S1. Growth of C. albicans on glucogenic amino acids. Thirteen glucogenic 
amino were chosen based on humans. C. albicans WT and gre3/xyl2 were grown on these 
amino acids as the only source of carbon. It was observed that the pathogen lacks some of 
the necessary enzymes to metabolize Cys, His, Met and Val, and does not grow. The 
pathogen has the enzymes to metabolism Arg and Gly but is still unable to grow. 
Presence and absence of enzymes was verified through the Candida Genome Database. 
 
Figure S2. Plasmid map of pAL001. This plasmid contains ScGRE3 in the pRS314 
vector backbone. Plasmid map was generated using the program MacVector. 
 
Figure S3. Plasmid map of pAL002. This plasmid contains CaScGRE3 in the pRS314 
vector backbone. Plasmid map was generated using the program MacVector. 
 
Figure S4. Plasmid map of pAL003. This plasmid contains CaScGRE3 in the 
CIpACT1-CYC vector backbone. Plasmid map was generated using the program 
MacVector. 
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Figure S5. Adapted-evolution growth assay conditions. The double complemented 
strain CA271 was plated in three different conditions before assayed in liquid xylose: (A) 
Plated on 2% glucose. (B) Plated on 2% xylose. (C) Plated on 2% xylose, then replica 
plated on 2% glucose. 
 
Figure S6. Adapted-evolution growth assay on Day 5. CA271 colonies plated in 
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CGD orf WT vs. null in SX CGD Name Process
orf19.4317 301.9175 GRE3 D-xylose catabolic process
orf19.7585 248.171 INO1 carb metabolic process
orf19.7676 137.805 XYL2 redox process
orf19.1715 24.922 IRO1 iron ion homeostasis
orf19.5971 18.523 MTC6 ortholog -
orf19.6486 18.4055 LDG3 -
orf19.1982 12.4795 - aerobic respiration
orf19.5437 12.2255 RHR2 cell-abiotic subtrate adhesion
orf19.4402 10.87 - -
orf19.5587 7.4925 - cellular response to methylmercury
orf19.1587 7.2455 - carbohydrate transport
orf19.4444 7.122 - phenotype switching
orf19.4773 6.672 AOX2 alternative respiration
orf19.1614 6.6245 MEP1 ammonium transport
orf19.2108 6.4985 SOD6 redox process
orf19.5025 6.3245 MET3 sulfate assimilation
orf19.11 5.468 - -
orf19.339 5.1835 NDE1 NADH oxidation
orf19.38 4.8775 - -
orf19.6814 4.7935 TDH3 redox process
orf19.1868 4.761 RNR22 redox process
orf19.7680 4.705 CTA26 positive reg of transcription
orf19.2532 4.5995 PRS prolyl-tRNA aminoacylation
orf19.5305 4.48 RHD3 fungal-type cell wall organization
orf19.3575 4.375 CDC19 cellular response to starvation
orf19.395 4.276 ENO1 carbon utilization
orf19.5620 4.2395 - biocsynthetic process
orf19.6959 4.0665 HOM32 -
orf19.1306 4.0135 - redox process
Expression Level: No	Data <	0.5 0.5	-	2 >	2	-	6 >	6	-	10 >	10







CGD orf CA271 vs. null in SX CGD Name Process
orf19.4317 105.2631579 GRE3 D-xylose catabolic process
orf19.6486 23.52941176 LDG3 -
orf19.7585 15.50387597 INO1 inositol biosynthetic process
orf19.616 14.18439716 - -
orf19.1715 11.9047619 IRO1 cellular iron ion homeostasis
orf19.1614 11.83431953 MEP1 ammonium transport
orf19.4444 10.47120419 PHO15 phenotypic switching
orf19.2645 8.695652174 - -
orf19.1268 8.230452675 - -
orf19.4996 8.097165992 - -
orf19.4750 8.064516129 - -
orf19.3121 8 GST1 -
orf19.1780 7.90513834 - -
orf19.762 7.874015748 - -
orf19.2445 7.843137255 - amino acid transmembrane transport
orf19.140 7.722007722 - -
orf19.2889 7.662835249 - chromatin remodeling
orf19.6777 7.633587786 - -
orf19.2681 7.547169811 RBT7 ribonuclease activity
orf19.6807 7.142857143 - DNA integration
orf19.1763 6.666666667 IFR1 oxidation-reduction process
orf19.6366 6.666666667 - -
orf19.4472 6.369426752 - -
orf19.2197 6.211180124 - oxidation-reduction process
orf19.2280 6.211180124 ZCF10 filamentous growth in response to biotic stimulus
orf19.1473 6.042296073 - oxidation-reduction process
orf19.4239 6.024096386 - -
orf19.57 5.917159763 PSF2 DNA-dependent DNA replication
orf19.1716 5.899705015 URA3 adhesion of symbiont to host
orf19.7665 5.763688761 - mitochondrial respiratory chain complex IV assembly
orf19.3925 5.714285714 - -
orf19.584 5.681818182 - response to oxidative stress
orf19.848 5.649717514 PGA16 -
orf19.1638 5.555555556 - ER to Golgi vesicle-mediated transport
orf19.2475 5.524861878 PGA26 cellular response to starvation
orf19.1065 5.509641873 SSA2 interaction with host
orf19.6595 5.434782609 RTA4 cellular response to starvation
Expression Level: No	Data <	0.5 0.5	-	2 >	2	-	6 >	6	-	10 >	10






CGD orf WT vs. CA271 in SX CGD Name Process
orf19.7676 95.23809524 XYL2 redox process
orf19.1982 16.2601626 - role in aerobic respiration
orf19.7585 16.12903226 INO1 inositol biosynthetic process
orf19.5971 15.26717557 MTC6 ortholog -
orf19.4402 8.888888889 - -
orf19.4335 7.633587786 TNA1 -
orf19.5674 6.269592476 CGA10 ion homeostasis
orf19.7370 4.524886878 - basic amino acid transmembrane export from vacuole
orf19.2532 4.237288136 PRS prolyl-tRNA aminoacylation
orf19.2372 3.766478343 - DNA integration
orf19.2079 3.724394786 PHHB cellular response to starvation
orf19.4773 3.676470588 AOX2 alternative respiration
orf19.5373 3.597122302 - -
orf19.1366 3.521126761 - oxidation-reduction process
orf19.91 3.372681282 - -
orf19.7278 3.294892916 - -
orf19.1073 3.262642741 - -
orf19.2881 3.246753247 MNN4 cell wall mannoprotein biosynthetic process
orf19.5004 3.215434084 RAD54 mitotic nuclear division
orf19.4506 3.2 LYS22 lysine biosynthetic process via aminoadipic acid
orf19.7586 3.159557662 CHT3 carbohydrate metabolic process
orf19.5556 3.086419753 - -
orf19.1415 2.989536622 FRE10 iron ion transport
orf19.6070 2.928257687 ENA1 hyphal growth
orf19.6994 2.906976744 BAT22 branched-chain amino acid metabolic process
orf19.3526 2.820874471 ITR1 carbohydrate transport
orf19.7227 2.805049088 - mitotic spindle assembly checkpoint
orf19.3035 2.801120448 - mitotic sister chromatid segregation
orf19.1363 2.762430939 - ascospore formation
orf19.468 2.75862069 - -
orf19.6184 2.72851296 - -
orf19.2888 2.721088435 - ER to Golgi vesicle-mediated transport
orf19.2371 2.688172043 - -
orf19.6950 2.649006623 - basic amino acid transmembrane export from vacuole
orf19.822 2.649006623 HSP21 cellular response to oxidative stress
orf19.4502 2.642007926 - rRNA processing
Expression Level: No	Data <	0.5 0.5	-	2 >	2	-	6 >	6	-	10 >	10
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Table I Plasmids used in this study
Plasmid Description Reference
CIpACT-CYC ACT1p-CYC1t-RPS1-cURA3 Tripathi et al. 2002
pRS314 pBluescript, TRP1, CEN6, ARSH4 Sikorski et al. 1989
pl396 CIpACT-CYC with S. cerevisiae GRE3 (CTG/Leu to TTG) Harcus et al. 2013
pAL001 pRS314 with C. albicans ACT1p-ScGRE3-RPS1 This study
pAL002 pRS314 with C. albicans ACT1p-CaScGRE3-RPS1 This study
pAL003 CIpACT-CYC with C. albicans ACT1p-CaScGRE3-RPS1 This study
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Table 2 
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Table 3 
Table III Strains used in this study
Strain Genotype Reference
SC5314 Candida albicans wild-type clinical isolate Gillum et al. 1984
SN148 arg4Δ/arg4Δ leu2Δ/leu2Δ his1Δ/his1Δ ura3Δ::imm434/ura3Δ::imm434 iro1Δ::imm434/iro1Δ::imm434 Noble et al. 2005
gre3 SN148 gre3::HIS3/gre3::ARG4 Harcus et al. 2013
xyl2 SN148 xyl2::HIS3/xyl2::ARG4 Harcus et al. 2013
gre3/xyl2 gre3::HIS1/gre3::ARG4 xyl2::LEU2/xyl2::FRT Harcus et al. 2013
CDH139 xyl2::HIS1/xyl2::ARG4 RPS1/RPS1:: [CIpACT-CYC S. cerevisiae SOR1 (pDH279)] Harcus et al. 2013
CA256 gre3::HIS1/gre3::ARG4 RPS1/RPS1:: [CIpACT-CYC S. cerevisiae GRE3 (CTG/Leu to TTG) (pl396)] Harcus et al. 2013
CA270 gre3/xyl2 RPS1/RPS1:: [CIpACT-CYC S. cerevisiae SOR1 (pDH279)] ura3-/ura3- This study
CA271 gre3/xyl2 RPS1/RPS1:: [CIpACT-CYC S. cerevisiae SOR1 (pDH279)]::[CIpACT-CYC S. cerevisiae  GRE3 (pl396)] This study
BY4743 MATa/MATalpha his3Δ1/his3Δ1 leu2Δ0/leu2Δ0 lys2Δ0/LYS2 MET15/met15Δ0 ura3Δ0/ura3Δ0(4741/4742) Brachmann et al. 1998
W303-1A MATa ade2-1 canl-100 his3-11,15 leu2-3,112 trpl-l ura3-1 Thomas et al. 1989
AL001 W303-1A:: [pRS314 with C. albicans ACT1-CaScGRE3-RPS1 (pAL002)] This study
AL002 gre3::HIS1/gre3::ARG4 RPS1/RPS1:: [CIpACT-CYC CaScGRE3 (pAL003)] This study
AL003 gre3/xyl2 RPS1/RPS1:: [CIpACT-CYC S. cerevisiae SOR1 (pDH279)]::[CIpACT-CYC CaScGRE3 (pAL003)] This study
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Supplementary 1: Glucogenic Amino Acids Growth Chart 
 
Amino Acid Enzyme Involved 
Gene in C. 
albicans 
End Product 
L-Serine Dehydratase (1) ILV1 Pyruvate 
L-Cysteine Transaminase (2) None Pyruvate 
L-Alanine Transaminase (1) ALT1 Pyruvate 
L-Histidine Ammonia Lyase (4) None L-Glutamate 
L-Aspartate Ammonia Lyase (1) None Fumarate 
L-Aspartate Transaminase (1) AAT21 Oxaloacetate 
L-Asparagine Asparaginase (1) orf19.7593 L-Aspartate 
L-Glutamate Dehydrogenase (1) GDH2 α-Ketoglutarate 


























Grows (has necessary enzymes) 
 
Does not grow (lacks necessary enzymes) 
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Supplementary 4: pAL003 Plasmid Map 
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